WHO ICTRP trial
PEERLESS study
NL-OMON51587 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON51587 |
|---|---|
| Public title | PEERLESS study |
| Scientific title | PEERLESS study - PEERLESS study |
| Primary sponsor | Inari Medical Europe GmbH |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Countries | Germany;Netherlands;Switzerland;United States of America |
| Conditions | Pulmonary embolism;10003184;10014523;Pulmonary embolism |
| Interventions | N/A ;Catheter-directed;FlowTriever system;Pulmonary embolism;Thromboloysis |
| Registration date | Dec 8, 2022 |
| Target size | 12 |
| Secondary IDs | NL81035.078.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: